Record title
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
Record identifier
TN_cdi_proquest_miscellaneous_2301881378
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2301881378
Share
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
About this item
Full title
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
The lancet oncology, 2019, Vol.20 (12), p.1681-1690
Record Identifier
TN_cdi_proquest_miscellaneous_2301881378
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2301881378
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2301881378
Other Identifiers
ISSN
E-ISSN
DOI
